Trial intelligence / Profile preview

Dabigatran vs Warfarin for AF after bioprosthesis replacement

NCT01868243Phase 3Terminated

Sponsor
Hospital Ana Nery
Start
Aug 2013
Primary completion
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dabigatran in Atrial fibrillation (AFib), sponsored by Hospital Ana Nery. Started Aug 2013; status: terminated.

02

Drugs

dabigatran
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01868243.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01868243.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call